EverSource Wealth Advisors’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.3K | Buy |
766
+673
| +724% | +$22.2K | ﹤0.01% | 2105 |
|
|
2025
Q1 | $3.74K | Buy |
93
+42
| +82% | +$1.69K | ﹤0.01% | 2637 |
|
|
2024
Q4 | $2.4K | Buy |
51
+13
| +34% | +$611 | ﹤0.01% | 2646 |
|
|
2024
Q3 | $2.01K | Sell |
38
-20
| -34% | -$1.06K | ﹤0.01% | 2548 |
|
|
2024
Q2 | $3.42K | Buy |
58
+7
| +14% | +$413 | ﹤0.01% | 2356 |
|
|
2024
Q1 | $3.13K | Buy |
51
+14
| +38% | +$858 | ﹤0.01% | 2230 |
|
|
2023
Q4 | $3.09K | Sell |
37
-57
| -61% | -$4.76K | ﹤0.01% | 2042 |
|
|
2023
Q3 | $2.77K | Buy |
94
+47
| +100% | +$1.39K | ﹤0.01% | 1910 |
|
|
2023
Q2 | $1.53K | Buy |
47
+35
| +292% | +$1.14K | ﹤0.01% | 2101 |
|
|
2023
Q1 | $422 | Buy |
+12
| New | +$422 | ﹤0.01% | 2260 |
|